Free Trial
CVE:LBL

Lattice Biologics (LBL) Stock Price, News & Analysis

C$0.04
0.00 (0.00%)
(As of 06/3/2021)

About Lattice Biologics Stock (CVE:LBL)

Key Stats

Today's Range
C$0.04
C$0.04
50-Day Range
C$0.04
C$0.04
52-Week Range
C$0.03
C$0.13
Volume
114,000 shs
Average Volume
468,022 shs
Market Capitalization
C$5.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.

Receive LBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lattice Biologics and its competitors with MarketBeat's FREE daily newsletter.

LBL Stock News Headlines

Best Lattice Alternatives Of 2024
IVBIY Innovent Biologics, Inc.
625,000% Gain
The recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull run is over. But if history has taught us anything, it’s that this is only the beginning.
Lattice Biologics Ltd (LBLh)
Lattice Semiconductor Corp LSCC Stock Quote
See More Headlines

LBL Stock Analysis - Frequently Asked Questions

Lattice Biologics' stock was trading at C$0.04 at the start of the year. Since then, LBL shares have increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2024 here
.

Shares of LBL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lattice Biologics investors own include 50904 (GRC.V) (GRC), Air Canada (AC), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO) and Antibe Therapeutics (ATE).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.56 million
Book Value
C$0.00 per share

Miscellaneous

Free Float
N/A
Market Cap
C$5.13 million
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (CVE:LBL) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners